Literature DB >> 18691083

Chemically-modified HA for therapy and regenerative medicine.

Glenn D Prestwich1, Jing-Wen Kuo.   

Abstract

Hyaluronan (HA) is a very useful polymer, but its properties sometimes need to be altered or enhanced by chemical modification for biomedical applications. A wide variety of HA derivatives are currently used for eye surgery, joint viscoelastic supplementation, and anti-adhesion films. The future promises to deliver new classes of HA-based reagents as well as new polymers that can be used in situ with living cells or within the body.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691083     DOI: 10.2174/138920108785161523

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  29 in total

Review 1.  Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine.

Authors:  Glenn D Prestwich
Journal:  J Control Release       Date:  2011-04-14       Impact factor: 9.776

2.  Imaging of homeostatic, neoplastic, and injured tissues by HA-based probes.

Authors:  Mandana Veiseh; Daniel Breadner; Jenny Ma; Natalia Akentieva; Rashmin C Savani; Rene Harrison; David Mikilus; Lisa Collis; Stefan Gustafson; Ting-Yim Lee; James Koropatnick; Leonard G Luyt; Mina J Bissell; Eva A Turley
Journal:  Biomacromolecules       Date:  2011-12-12       Impact factor: 6.988

Review 3.  Organotypic 3D cell culture models: using the rotating wall vessel to study host-pathogen interactions.

Authors:  Jennifer Barrila; Andrea L Radtke; Aurélie Crabbé; Shameema F Sarker; Melissa M Herbst-Kralovetz; C Mark Ott; Cheryl A Nickerson
Journal:  Nat Rev Microbiol       Date:  2010-11       Impact factor: 60.633

4.  Chemical biologists gather in Heidelberg.

Authors:  Maja Köhn; Carsten Schultz
Journal:  Nat Chem Biol       Date:  2009-02       Impact factor: 15.040

5.  Modified High-Molecular-Weight Hyaluronan Promotes Allergen-Specific Immune Tolerance.

Authors:  John A Gebe; Koshika Yadava; Shannon M Ruppert; Payton Marshall; Paul Hill; Ben A Falk; Johanna M Sweere; Hongwei Han; Gernot Kaber; Ingrid A Harten; Carlos Medina; Katalin Mikecz; Steven F Ziegler; Swathi Balaji; Sundeep G Keswani; Vinicio A de Jesus Perez; Manish J Butte; Kari Nadeau; William A Altemeier; Neil Fanger; Paul L Bollyky
Journal:  Am J Respir Cell Mol Biol       Date:  2017-01       Impact factor: 6.914

6.  Therapeutic potential of gel-based injectables for vocal fold regeneration.

Authors:  Rebecca S Bartlett; Susan L Thibeault; Glenn D Prestwich
Journal:  Biomed Mater       Date:  2012-03-29       Impact factor: 3.715

7.  The effect of mesenchymal stromal cell-hyaluronic acid hydrogel constructs on immunophenotype of macrophages.

Authors:  Summer E Hanson; Suzanne N King; Jaehyup Kim; Xia Chen; Susan L Thibeault; Peiman Hematti
Journal:  Tissue Eng Part A       Date:  2011-06-24       Impact factor: 3.845

8.  Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities.

Authors:  Bryan P Toole
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

9.  Biophysical properties of phenyl succinic acid derivatised hyaluronic acid.

Authors:  Maria Teresa Neves-Petersen; Søren Klitgaard; Esben Skovsen; Steffen B Petersen; Kristoffer Tømmeraas; Khadija Schwach-Abdellaoui
Journal:  J Fluoresc       Date:  2009-11-28       Impact factor: 2.217

10.  Engineering a clinically-useful matrix for cell therapy.

Authors:  Glenn D Prestwich
Journal:  Organogenesis       Date:  2008-01       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.